103 related articles for article (PubMed ID: 25850393)
1. Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients.
Zou MX; Huang W; Wang XB; Li J; Lv GH; Wang B; Deng YW
Eur Spine J; 2015 Aug; 24(8):1738-46. PubMed ID: 25850393
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic implications of CD8
Zou MX; Guo KM; Lv GH; Huang W; Li J; Wang XB; Jiang Y; She XL
Cancer Immunol Immunother; 2018 Feb; 67(2):209-224. PubMed ID: 29051990
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological implications of TIM3
Zhou J; Jiang Y; Zhang H; Chen L; Luo P; Li L; Zhao J; Lv F; Zou D; Zhang Y; Jing Z
Cancer Immunol Immunother; 2019 Jul; 68(7):1157-1169. PubMed ID: 31197461
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-Inducible Factor-1α (HIF-1α) as a Factor to Predict the Prognosis of Spinal Chordoma.
He G; Liu X
Spine (Phila Pa 1976); 2024 May; 49(9):661-669. PubMed ID: 38251727
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma.
Duan Z; Shen J; Yang X; Yang P; Osaka E; Choy E; Cote G; Harmon D; Zhang Y; Nielsen GP; Spentzos D; Mankin H; Hornicek F
J Orthop Res; 2014 May; 32(5):695-701. PubMed ID: 24501096
[TBL] [Abstract][Full Text] [Related]
6. MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors.
Nikolova E; Nankova A; Kalenderova S; Georgieva B; Hadzhiyanev A; Bichev S; Savov A; Todorova A; Mitev V; Elenkova A
Exp Clin Endocrinol Diabetes; 2024 May; 132(5):240-248. PubMed ID: 38354830
[TBL] [Abstract][Full Text] [Related]
7. Low expression of miRNA-1290 associated with local invasion and recurrence in sacral chordoma.
Wang Y; Chen K; Chen H; Zhang K; Lu J; Mao H; Yang H
Int J Clin Exp Pathol; 2017; 10(11):10934-10940. PubMed ID: 31966437
[TBL] [Abstract][Full Text] [Related]
8. miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma.
Ayoubian H; Heinzelmann J; Hölters S; Khalmurzaev O; Pryalukhin A; Loertzer P; Heinzelbecker J; Lohse S; Geppert C; Loertzer H; Wunderlich H; Bohle RM; Stöckle M; Matveev VB; Hartmann A; Junker K
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33807023
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.
Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
Front Oncol; 2020; 10():596330. PubMed ID: 33282745
[TBL] [Abstract][Full Text] [Related]
10. Primary Bone Tumors: Epidemiologic Comparison of 9200 Patients Treated at Beijing Ji Shui Tan Hospital, Beijing, China, With 10 165 Patients at Mayo Clinic, Rochester, Minnesota.
Niu X; Xu H; Inwards CY; Li Y; Ding Y; Letson GD; Bui MM
Arch Pathol Lab Med; 2015 Sep; 139(9):1149-55. PubMed ID: 25978765
[TBL] [Abstract][Full Text] [Related]
11. Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma.
Feng Y; Shen J; Gao Y; Liao Y; Cote G; Choy E; Chebib I; Mankin H; Hornicek F; Duan Z
Oncotarget; 2015 May; 6(13):11139-49. PubMed ID: 25871477
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma.
Huang W; Yan YG; Wang WJ; Ouyang ZH; Li XL; Zhang TL; Wang XB; Wang B; Lv GH; Li J; Zou MX
Front Oncol; 2020; 10():556902. PubMed ID: 33194623
[TBL] [Abstract][Full Text] [Related]
13. miR-4716-3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population.
Nandwa JO; Mehmood A; Mahjabeen I; Raheem KY; Hamadou M; Raimi MZKA; Kayani MA
Noncoding RNA Res; 2024 Sep; 9(3):695-703. PubMed ID: 38577021
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of noncoding RNA in chordoma; implications in identifying potential targets for novel therapeutic approaches.
Ghosh PK; Ghosh A
Mol Biol Rep; 2024 Jan; 51(1):125. PubMed ID: 38236360
[TBL] [Abstract][Full Text] [Related]
15. Systematic analyzing a five- miRNA panel and its diagnostic value of plasma expression in colorectal cancer.
Li SQ; Xie LY; Cai ZM; Wei HT; Xie MZ; Hu BL; Ning SF
Mol Biol Rep; 2023 Sep; 50(9):7253-7261. PubMed ID: 37418078
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes and SNPs linked to harvest body weight of genetically improved rohu carp,
Nandanpawar P; Sahoo L; Sahoo B; Murmu K; Chaudhari A; Pavan Kumar A; Das P
Front Genet; 2023; 14():1153911. PubMed ID: 37359361
[TBL] [Abstract][Full Text] [Related]
17. Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels.
Rubino F; Alvarez-Breckenridge C; Akdemir K; Conley AP; Bishop AJ; Wang WL; Lazar AJ; Rhines LD; DeMonte F; Raza SM
Front Oncol; 2022; 12():997506. PubMed ID: 36248987
[TBL] [Abstract][Full Text] [Related]
18. Potential molecular mechanism in self-renewal is associated with miRNA dysregulation in sacral chordoma - A next-generation RNA sequencing study.
Bozsodi A; Scholtz B; Papp G; Sapi Z; Biczo A; Varga PP; Lazary A
Heliyon; 2022 Aug; 8(8):e10227. PubMed ID: 36033338
[TBL] [Abstract][Full Text] [Related]
19. miR-1290 inhibits chordoma cell proliferation and invasion by targeting Robo1.
Wang B; Zhang K; Chen H; Lu J; Wu G; Yang H; Chen K
Transl Cancer Res; 2019 Apr; 8(2):542-551. PubMed ID: 35116786
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
